Gait control and executive dysfunction in early schizophrenia.

Dysexecutive functioning, which is described as an enduring core feature of schizophrenia, has been associated with gait disorders. However, few studies have reported gait disorders in schizophrenia patients. The objective of this study was to examine the association between executive dysfunction and gait performance in recent-onset schizophrenia patients using the dual task paradigm. Thirty-two subjects participated to the study: 17 with recent-onset schizophrenia and 15 healthy age-matched controls. Executive functions were evaluated using the Frontal Assessment Battery, Stroop and Trail-Making tests. Mean values and coefficients of variation (CV) of the temporal gait parameters while single tasking (just walking) and while dual tasking (walking and forward counting, walking and backward counting, walking and verbal fluency) were measured using the SMTEC(®)-footswitch system. We focused on the CV of stride time as this measure has been shown to be the most representative parameter of higher gait control. A strong effect of the stride time was found in the group factor for the verbal fluency dual-task when compared to controls (Cohen's d mean = 1.28 and CV = 1.05). The effect was lower in the other dual tasks, and insignificant in the single task of walking. This study shows that patients exhibit higher stride-to-stride variability while dual tasking than controls. It also shows a stronger impact of verbal fluency on gait regularity compared to the other dual tasks revealing a relationship between the executive dysfunction and gait modification. Those results are in line with the idea that schizophrenia implies not only cognitive but also motor functioning and coordination impairment.

[Paranoia and persecution]. / Paranoia et persécution.

The idea of paranoia has existed since Antiquity, but it was only in the 19th centurythat psychiatrists became interested in it and sought to describe it. Delusion and the feeling of persecution are common in all paranoiacs. The origins of the disease can be found in the patient's psychic structure. Establishing and maintaining contact with a caregiver is one way of helping the patient.

Attitudes of patients and family members towards implantable psychiatric medication.

INTRODUCTION: Medication is a necessary part of treatment for severe psychiatric illnesses such as schizophrenia and nonadherence to prescribed medication is one of the most important public health issues in psychiatry today. The devastating consequences of nonadherence have motivated the development of novel therapeutic strategies, including a new long-term implantable medication delivery system. METHODS: The current study assesses attitudes towards implantable medication in psychiatric patients and their family members. Patients included in the study had diagnoses of Schizophrenia, Schizoaffective Disorder, Mood or Anxiety related disorders. RESULTS: 49.62% of patients and 74.47% of family members endorse support for implantable medication. CONCLUSIONS: This study demonstrates that implants may be an acceptable alternative to oral and injectable medication for a subset of psychiatric patients and their families.

Agency, the sense of presence, and schizophrenia.

The objective of this work is to evaluate the impact of agency deficiency on presence. We hypothesize that a deficit in agency, such as occurs in schizophrenia, has repercussions on the sense of presence as well as on performance in a sensorimotor test involving the body. Nineteen healthy controls and 19 stable patients with schizophrenia, matched by age and gender, participated in the study. We used new interactive technologies that enable the users to physically interact with a virtual environment and simultaneously sees themselves performing the actions. Two conditions were balanced: the control condition in which the participant see himself or herself doing the test, and the mask condition, in which the central part of the participant's body is hidden. At the end of the test, all participants completed a questionnaire on presence. The results show that control participants performed better than those with schizophrenia in the control condition. On the contrary, in the mask condition, their performance was significantly lower, whereas participants with schizophrenia obtained the same score as in the control condition. Controls also rated higher in the scale of presence than did participants with schizophrenia. Those results seem to corroborate a relationship between agency and presence. The body awareness and the self in schizophrenia are discussed in the light of agency.